Abstract: The present invention relates to an erodible tablet comprising a therapeutic peptide which is suitable for oral administration and, in addition, to a non-granulation process for making the erodible tablet.
| # | Name | Date |
|---|---|---|
| 1 | 202317082830-STATEMENT OF UNDERTAKING (FORM 3) [05-12-2023(online)].pdf | 2023-12-05 |
| 2 | 202317082830-Sequence Listing in txt [05-12-2023(online)].txt | 2023-12-05 |
| 3 | 202317082830-Sequence Listing in PDF [05-12-2023(online)].pdf | 2023-12-05 |
| 4 | 202317082830-REQUEST FOR EXAMINATION (FORM-18) [05-12-2023(online)].pdf | 2023-12-05 |
| 5 | 202317082830-PRIORITY DOCUMENTS [05-12-2023(online)].pdf | 2023-12-05 |
| 6 | 202317082830-POWER OF AUTHORITY [05-12-2023(online)].pdf | 2023-12-05 |
| 7 | 202317082830-FORM 18 [05-12-2023(online)].pdf | 2023-12-05 |
| 8 | 202317082830-FORM 1 [05-12-2023(online)].pdf | 2023-12-05 |
| 9 | 202317082830-DECLARATION OF INVENTORSHIP (FORM 5) [05-12-2023(online)].pdf | 2023-12-05 |
| 10 | 202317082830-COMPLETE SPECIFICATION [05-12-2023(online)].pdf | 2023-12-05 |
| 11 | 202317082830-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [05-12-2023(online)].pdf | 2023-12-05 |
| 12 | 202317082830-Proof of Right [17-05-2024(online)].pdf | 2024-05-17 |
| 13 | 202317082830-FORM 3 [17-05-2024(online)].pdf | 2024-05-17 |